Welcome to the Zhao Group

Yingqi Zhao received her PhD in biostatistics from the University of North Carolina, Chapel Hill in 2012. She is currently a Professor at Fred Hutchinson Cancer Center. Her research focus includes methodologies for precision medicine, dynamic treatment regimes, clinical trials design, real-world studies and machine learning. Specific applications of these work include cancer treatment and prevention, health care delivery for complex type II diabetes patients and childhood obesity surveillance. Her work in personalized medicine is particularly notable for these applications, which have been the basis for much subsequent work on developing biomarker-based treatment rules. She is actively engaged with collaborations with the SWOG clinical oncology cooperative group and the Early Detection Research Network.

Our research has been supported by NIH, Hope Foundation and PCORI.